Home › Products › Oncology › Rahika 200mg Tablet
Rahika 200mg Tablet
Salt Composition: CAPMATINIB
- Manufacturer: NOVARTIS INDIA LTD
- Pack Size: 12 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 200MG
- Prescription Required
- Storage: Rahika 200 mg tablet storage conditions are: Store at 20°C to 25°C Protect the medicine from light and excessive moisture. Keep the medicine out of reach of children and pets If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
₹14625.00₹15454.60
Inclusive of all taxes
Product Introduction
Rahika 200mg tablet contains the active ingredient Capmatinib. It is an anti-cancer medicine that belongs to the class of medications called protein kinase inhibitors. It is used to treat adults with non-small cell lung cancer (NSCLC) that has spread to other body parts or is caused by a mutation in the gene that encodes the MET enzyme.
Do not take this medicine if you are allergic to Capmatinib or any ingredients in Rahika 200mg tablet. Inform your physician if you have or have ever had lung or breathing problems other than your lung cancer, liver problems, or pancreatic problems. Inform your physician if you experience any symptoms of an allergic reaction, including rash, hives, fever, difficulty breathing, or low blood pressure.
This medicine is not recommended for children and adolescents below 18 years of age. Avoid becoming pregnant and breastfeeding during treatment. Use effective contraception to prevent pregnancy.
The common side effects of Rahika 200mg tablet include swelling in the face and body, nausea, tiredness, vomiting, shortness of breath, and decreased appetite.
Rahika 200mg tablet may be substituted with other brands containing the same active ingredient, but only under your doctor's guidance.
Uses
Rahika 200 mg tablet uses are: Non-small cell lung cancer (NSCLC)
How it works
Rahika 200mg tablet is a kinase inhibitor that targets mesenchymal-epithelial transition (MET). It works by blocking the action of this abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
How to Use
It is an orally available prescription drug. Your doctor will decide the Rahika 200 mg dosage and duration of Rahika 200mg tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with water.
Side Effects
Rahika 200 mg tablet side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Swelling in the face, and body Decrease in appetite Nausea Cough Fatigue Serious Vomiting Liver injury Muscle pain Shortness of breath Lung infection Respiratory disease
References
- Capmatinib Tablets, PIL.; 2022. Accessed May 2, 2023. https://www.ema.europa.eu/en/documents/product-information/tabrecta-epar-product-information_en.pdf
- TABRECTATM - Capmatinib Tablets.; 2020. Accessed May 2, 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213591s000lbl.pdf
- Vansteenkiste JF, Van De Kerkhove C, Wauters E, Van Mol P. Capmatinib for the treatment of non-small cell lung cancer. Expert Review of Anticancer Therapy . 2019;19(8):659-671. doi: https://doi.org/10.1080/14737140.2019.1643239
- Choi W, Park SY, Lee Y, et al. The Clinical Impact of Capmatinib in the Treatment of Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation or Gene Amplification. Cancer Research and Treatment . Published online January 29, 2021. doi: https://doi.org/10.4143/crt.2020.1331
Safety Advice
Pregnancy: unsafe Do not take Rahika 200mg tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for 7 days after your last dose.
Lungs: unsafe Rahika 200mg tablet should be cautiously administered in patients with lung problems other than lung cancer. Inform your physician if you have any lung diseases before initiating the therapy.
Breastfeeding: unsafe Breastfeeding is not recommended in patients taking Rahika 200mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.